Image
07.07.2022
Data science investment to transform health of people with diabetes
We’ve joined forces with Health Data Research UK and the British Heart Foundation to launch a new initiat...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more